Analyst Ratings for Tarsus Pharmaceuticals (TARS)
TARS Rating Summary
TARS Price Target Summary
- Highest: $116.00 (Goldman Sachs)
- Lowest: $88.00 (H.C. Wainwright)
- Average: $101.14
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$101.14 (+48.6%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/24/2026 | Goldman Sachs | Andrea Newkirk | New Coverage | Buy (N/A) |
116.00 (N/A) |
77.08 (68.07) |
-11.69% | Details |
| 9/16/2026 | Barclays | Glen Santangelo | New Coverage | Overweight (N/A) |
110.00 (N/A) |
79.95 (68.07) |
-14.86% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
